Letaplimab
Modify Date: 2024-04-07 17:23:53
Letaplimab structure
|
Common Name | Letaplimab | ||
|---|---|---|---|---|
| CAS Number | 2283356-07-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LetaplimabLetaplimab (IBI-188) is a humanized IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPα. Letaplimab enhances tumor cell phagocytosis[1]. |
| Name | Letaplimab |
|---|
| Description | Letaplimab (IBI-188) is a humanized IgG4 anti-CD47 monoclonal antibody. CD47 is overexpressed on cancer cells, it is a ligand for SIRPα. Letaplimab enhances tumor cell phagocytosis[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |